The hypothalamus is integral to the regulation of body homeostasis, including food intake, energy balance, and blood pressure. Dysfunction of the hypothalamus has been associated with a broad range of disorders; many of which are sex-dependent in prevalence. Small nucleolar (sno) RNAs are a group of small RNAs located in nucleoli that modulate chemical modifications and maturation of ribosomal or other RNAs. Recent data suggest that snoRNA Snord116 is important for the pathogenesis of Prader-Willi syndrome (PWS) characterized by hyperphagia and obesity. The current study was conducted to assess a potential cellular link between Snord116 and phenotypes of PWS. Data from mice revealed Snord116 expression in the medial hypothalamus, particularly within nuclei that are part of feeding circuitry. High expression of Snord116 was evident in the paraventricular (PVN) and ventromedial (VMH) nuclei, but particularly prevalent in the arcuate nucleus (ARC) according to in situ hybridization. Snord116 expression level in ventral hypothalamic dissections including ARC was significantly greater (by 2-fold) than that in cortex; and its expression level in dorsal hypothalamic dissections including PVN was double that in cortex. The enhanced expression pattern of Snord116 in hypothalamic nuclei was observed at weaning and young adult stages, but less obvious neonatally when expression was significantly more widespread. Therefore the expression of Snord116 likely is regulated developmentally. These results provide a new lead for understanding the mechanism(s) related to hyperphagia and obesity symptoms in PWS patients.
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Introduction
The hypothalamus is located in the ventral part of the diencephalon. It functions as a master neuroendocrine control center by regulating the pituitary gland and controlling many functions throughout the body. The hypothalamus is implicated in a wide range of disorders. For instance, hypothalamic dysfunctions are associated with major depressive disorders (MDD) (Swaab et al., 2005) and metabolic disorders (e.g. hypothalamic obesity; Caqueret et al., 2005) . Although diseases related to hypothalamic dysfunction often develop in later stages of life, the etiologic factors often are rooted in development (Tobet et al., 2009) . Thus, studies of the hormonal and genetic factors that contribute to hypothalamic development are important in understanding disease mechanism, prevention, and treatment.
Much research on the molecular factors contributing to hypothalamic development is focused on signaling molecules * Corresponding author. Tel.: +1 970 491 1672; fax: +1 970 491 7907.
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(e.g. steroid hormones, transmitters, peptides, etc.) and transcription factors (McClellan et al., 2006; Morton et al., 2006; Tobet et al., 2009; Shimogori et al., 2010) . The current study focuses on a different class of molecules: small nucleic acid polymers in the brain. Non-coding RNAs account for about half of transcribed RNAs (Mattick, 2005) . However, it has not been recognized until recent years that transcribed non-coding RNAs may have a number of important cellular functions (Mattick, 2005) . Studies of neurodevelopment indicate that small RNAs play roles in cell fate determination during neuronal differentiation (Li and Jin, 2010) . On the other hand, in mature neurons small RNAs may regulate gene expression and be involved in cognitive brain functions (Schratt, 2009) . Considering that non-coding RNAs can be just as important as protein-coding RNAs in the nervous system, it is important to consider the possible regulatory roles of small RNAs on hypothalamic development and function and their potential involvement in disease.
Among non-coding RNAs, one particular small nucleic acid sequence has been related to the pathogenesis of Prader-Willi syndrome (PWS) and its symptoms of appetite disorder and obesity. PWS is a disease caused by defects in certain imprinted genes. About
